Tenecteplase improved functional outcome in patients with LVO presenting beyond 4.5 hours who had salvageable brain tissue but no access to endovascular therapy.
More Trial Evidence Supports Tenecteplase for Acute Stroke Thrombolysis tctmd.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tctmd.com Daily Mail and Mail on Sunday newspapers.
The International Stroke Conference 2024 will be held Feb. 7-9 in Phoenix, Arizona. According to program planners with the American Stroke Association, a division of the American Heart Association, findings from late-breaking science will include multiple high profile randomized clinical trials like RESILIENT-Extend, EMBOLISE, STEM, ZODIAC, among many others.